• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

监督下的物理治疗与多发性肌炎/皮肌炎——文献系统综述

Supervised Physical Therapy and Polymyositis/Dermatomyositis-A Systematic Review of the Literature.

作者信息

Corrado Bruno, Ciardi Gianluca, Lucignano Laura

机构信息

Department of Public Health, Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy.

出版信息

Neurol Int. 2020 Nov 24;12(3):77-88. doi: 10.3390/neurolint12030015.

DOI:10.3390/neurolint12030015
PMID:33255200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7768488/
Abstract

OBJECTIVE

to find the most up-to-date evidence of the effectiveness and safety of supervised physical therapy in polymyositis/dermatomyositis patients.

METHODS

a systematic review of the literature in the main scientific databases was carried out. We searched for randomized controlled trials concerning supervised physical therapy and polymyositis/dermatomyositis. The PICOS method was used for the formulation of the clinical query. Methodological quality and the level of evidence of the included studies were assessed using the modified Jadad scale and the Oxford Centre for Evidence-Based Medicine Levels of Evidence guide, respectively.

RESULTS

a total of 2591 articles were found. By applying the inclusion/exclusion criteria, six randomized controlled clinical trials were admitted to the final phase of the review. The compared approaches concerned supervised exercise programs based on strategies of muscle strengthening or aerobic work. Following these exercises, an increase in the maximum rate of oxygen consumption, a decrease in creatine phosphokinase levels, an enhancement in the patient's aerobic performance and an improvement in the quality of life indexes were registered. The methodological quality of the included studies ranged from 3 to 4.5. All the studies were classified as presenting an evidence level of 2b.

CONCLUSIONS

supervised physical therapy in polymyositis/dermatomyositis is an effective, safe and free-of-contraindications tool to be used both in the acute and in the established phases of the pathology. However, further and higher-quality studies are necessary to confirm those findings, to clarify the timing of exercise delivery and to guide the choice towards different types of muscle contraction exercises.

摘要

目的

寻找关于在多发性肌炎/皮肌炎患者中进行监督下物理治疗的有效性和安全性的最新证据。

方法

对主要科学数据库中的文献进行系统综述。我们搜索了有关监督下物理治疗和多发性肌炎/皮肌炎的随机对照试验。采用PICOS方法制定临床问题。分别使用改良的Jadad量表和牛津循证医学中心证据水平指南评估纳入研究的方法学质量和证据水平。

结果

共找到2591篇文章。通过应用纳入/排除标准,6项随机对照临床试验进入综述的最后阶段。比较的方法涉及基于肌肉强化或有氧运动策略的监督运动计划。进行这些运动后,记录到最大耗氧率增加、肌酸磷酸激酶水平降低、患者有氧运动能力增强以及生活质量指数改善。纳入研究的方法学质量在3至4.5之间。所有研究均被归类为证据水平为2b。

结论

在多发性肌炎/皮肌炎中,监督下物理治疗是一种有效、安全且无禁忌证的工具,可用于疾病的急性期和稳定期。然而,需要进一步的高质量研究来证实这些发现,阐明运动实施的时机,并指导对不同类型肌肉收缩运动的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/7768488/0e90f625efc9/neurolint-12-00015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/7768488/0e90f625efc9/neurolint-12-00015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea20/7768488/0e90f625efc9/neurolint-12-00015-g001.jpg

相似文献

1
Supervised Physical Therapy and Polymyositis/Dermatomyositis-A Systematic Review of the Literature.监督下的物理治疗与多发性肌炎/皮肌炎——文献系统综述
Neurol Int. 2020 Nov 24;12(3):77-88. doi: 10.3390/neurolint12030015.
2
Physical exercise for dermatomyositis and polymyositis: a systematic review and meta-analysis.物理治疗皮肌炎和多发性肌炎:系统评价和荟萃分析。
Clin Rheumatol. 2022 Sep;41(9):2635-2646. doi: 10.1007/s10067-022-06281-1. Epub 2022 Jul 12.
3
Strength training and aerobic exercise training for muscle disease.针对肌肉疾病的力量训练和有氧运动训练。
Cochrane Database Syst Rev. 2013 Jul 9(7):CD003907. doi: 10.1002/14651858.CD003907.pub4.
4
Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis -- a randomized controlled single-blinded study with a 2-year followup.近期发病的多发性肌炎和皮肌炎患者的阻力性家庭锻炼——一项为期2年随访的随机对照单盲研究
J Rheumatol. 2014 Jun;41(6):1124-32. doi: 10.3899/jrheum.131145. Epub 2014 May 1.
5
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.皮肌炎和多发性肌炎的免疫抑制剂及免疫调节治疗。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003643. doi: 10.1002/14651858.CD003643.pub2.
6
WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.撤回:皮肌炎和多发性肌炎的免疫抑制剂及免疫调节治疗。
Cochrane Database Syst Rev. 2009 Oct 7(4):CD003643. doi: 10.1002/14651858.CD003643.pub3.
7
Safety and possible effects of low-intensity resistance training associated with partial blood flow restriction in polymyositis and dermatomyositis.低强度抗阻训练联合部分血流限制在多发性肌炎和皮肌炎中的安全性及可能的影响
Arthritis Res Ther. 2014 Oct 25;16(5):473. doi: 10.1186/s13075-014-0473-5.
8
Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls.成人皮肌炎/多肌炎患者与健康对照者的有氧能力。
Arch Phys Med Rehabil. 2000 Jan;81(1):1-5. doi: 10.1016/s0003-9993(00)90212-0.
9
The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.皮肌炎和多发性肌炎免疫治疗的证据:一项系统综述。
Clin Rheumatol. 2015 Dec;34(12):2089-95. doi: 10.1007/s10067-015-3059-y. Epub 2015 Aug 25.
10
Resistive exercise in the rehabilitation of polymyositis/dermatomyositis.抗阻运动在多发性肌炎/皮肌炎康复中的应用
J Rheumatol. 1993 Aug;20(8):1340-4.

引用本文的文献

1
Refractory Severe Anti-SRP Myopathy that Improved with Long-term Rehabilitation Therapy: A Case Report.长期康复治疗改善难治性重症抗信号识别颗粒肌病:一例报告
Prog Rehabil Med. 2025 Jan 22;10:20250003. doi: 10.2490/prm.20250003. eCollection 2025.
2
Targeting Weakness With a Combination of Isotonic Exercises in Dermatomyositis With Polyneuropathy: A Case Report.针对合并多发性神经病的皮肌炎采用等张运动组合疗法改善肌无力:病例报告
Cureus. 2024 Jan 24;16(1):e52873. doi: 10.7759/cureus.52873. eCollection 2024 Jan.
3
Rehabilitation and Exercise in Dermatomyositis: A Case Report and Narrative Review of the Literature.

本文引用的文献

1
Evidence-Based Physical Therapy for Individuals with Rett Syndrome: A Systematic Review.雷特综合征患者的循证物理治疗:一项系统评价
Brain Sci. 2020 Jun 30;10(7):410. doi: 10.3390/brainsci10070410.
2
Rehabilitation management of Pompe disease, from childhood trough adulthood: A systematic review of the literature.庞贝病从儿童期到成年期的康复管理:文献系统综述
Neurol Int. 2019 Jun 18;11(2):7983. doi: 10.4081/ni.2019.7983.
3
Comparison of the 2017 EULAR/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies.
皮肌炎的康复与运动:一例病例报告及文献综述
Cureus. 2022 Dec 28;14(12):e33034. doi: 10.7759/cureus.33034. eCollection 2022 Dec.
比较 2017 年 EULAR/ACR 标准与 Bohan 和 Peter 标准在特发性炎性肌病分类中的应用。
Clin Rheumatol. 2019 Jul;38(7):1931-1934. doi: 10.1007/s10067-019-04512-6. Epub 2019 Mar 22.
4
Cardiac Manifestations in Idiopathic Inflammatory Myopathies: An Overview.特发性炎性肌病的心脏表现:综述
Cardiol Rev. 2019 May/Jun;27(3):131-137. doi: 10.1097/CRD.0000000000000241.
5
Dermatomyositis: Current concepts.皮肌炎:当前概念
Clin Dermatol. 2018 Jul-Aug;36(4):450-458. doi: 10.1016/j.clindermatol.2018.04.003. Epub 2018 Apr 12.
6
The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature.利妥昔单抗在特发性炎性肌病中的应用:单中心队列描述及文献综述
Reumatismo. 2018 Jul 6;70(2):78-84. doi: 10.4081/reumatismo.2018.1011.
7
Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review.利妥昔单抗治疗抗合成酶综合征相关的间质性肺病:一项多中心回顾性病例研究。
J Rheumatol. 2018 Jun;45(6):841-850. doi: 10.3899/jrheum.170541. Epub 2018 Apr 1.
8
Bench to bedside review of myositis autoantibodies.肌炎自身抗体的 bench 到床边回顾
Clin Mol Allergy. 2018 Mar 7;16:5. doi: 10.1186/s12948-018-0084-9. eCollection 2018.
9
First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome.骨髓增生异常综合征患者抗TIF1γ皮肌炎的首例报告。
Reumatismo. 2017 Aug 3;69(2):75-77. doi: 10.4081/reumatismo.2017.923.
10
Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis.特发性炎性肌病:分类及发病机制影响的综述
Int J Mol Sci. 2017 May 18;18(5):1084. doi: 10.3390/ijms18051084.